Latest news in Benign Prostatic Hyperplasia BPH
Urologix Reports Fiscal 2008 Fourth Quarter & Fiscal Year 2008 Results (Centre Daily Times)
28 Aug 2008
Urologix(R), Inc. (NASDAQ:ULGX), today reported financial results for the fourth quarter ended June 30, 2008 and for fiscal year 2008. Revenue for the fourth quarter was $3.7 million or 24 percent less than the $4.8 million reported in the same period of fiscal 2007 and 18 percent more than the $3.1 million reported in the third quarter of this fiscal year. Net loss for the fourth quarter was ...28 Aug 2008
MINNEAPOLIS----Urologix®, Inc. , today reported financial results for the fourth quarter ended June 30, 2008 and for fiscal year 2008. Revenue for the fourth quarter was $3.7 million or 24 percent less than the $4.8 million reported in the same period of fiscal 2007 and 18 percent more than the $3.1 million reported in the third quarter of this fiscal year.25 Aug 2008
Neurocrine Biosciences, Inc. announced today that Kevin Gorman, President and Chief Executive Officer will be presenting at both the Thomas Weisel Healthcare Conference in Boston and the NewsMakers in the Biotech Industry Conference in New York.In this category: Websites: 0, Number of pages: 0, Last updated: 30 Aug 2008
